We are The Machine Learning Immunology Company. Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using our IMPACT™ platform, we are addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery – structural biology, protein engineering and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub.
Location: United States, Massachusetts, Watertown
Employees: 11-50
Total raised: $222M
Founders name: Jo Viney
Founders Related Locations: United States, Massachusetts, Watertown; Canada, Ontario, Toronto; United States, California, San Francisco; United States, Connecticut, Farmington; United States, Massachusetts, Cambridge
Investors 4
| Date | Name | Website |
| - | Old Silver... | oldsilverv... |
| 09.02.2022 | Lightspeed... | lsvp.com |
| 31.08.2024 | SymBiosis | symbiosis.... |
| 26.04.2022 | GV | gv.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 04.12.2023 | Series B | $121M | - |
| 10.02.2022 | Series A | $101M | Lightspeed... |
Persons 1
| Date | First Name | Last Name | Title | |||
| - | Jo | Viney | Founder, P... | linkedin.c... | - | - |
Mentions in press and media 9
| Date | Title | Description |
| 04.12.2023 | Seismic Therapeutic raises $121 million in funding to accelerate immunology drug development using machine learning | Research published on the NIH website reveals a daunting statistic: nine out of ten new drug candidates fail to navigate through clinical trials and gain regulatory approval. The findings further underscore the substantial challenges: a sta... |
| 04.12.2023 | Seismic Therapeutic Closes $121 Million Series B Financing | CAMBRIDGE, MA, Seismic Therapeutic has closed a $121M Series B funding led by Bessemer Venture Partners. >> Click here for more funding data on Seismic Therapeutic >> To export Seismic Therapeutic funding data to PDF and Exc... |
| 04.12.2023 | Seismic Therapeutic Closes $121M Series B Financing | Seismic Therapeutic, a Cambridge, MA-based machine learning immunology company, raised $121M in Series B funding. The round, which brought the total amount to $222M, was led by Bessemer Venture Partners with participation from other new inv... |
| 28.03.2023 | Seismic Therapeutic Appoints Melanie Manning as Chief People Officer | Seismic Therapeutic, a biotechnology company using machine learning for immunology drug development, announced that Melanie Manning has joined the company as Chief People Officer. She is an experienced and versatile human resources (HR) lea... |
| 10.02.2022 | Lightspeed leads $101M round for Seismic Therapeutic | Seismic Therapeutic has raised a $101 million Series A led by Lightspeed. Based in the Boston area, Seismic uses machine learning to accelerate immunology drug development. The company plans to use the funding to advance its first two lead ... |
| 09.02.2022 | Seismic Therapeutic Launches with $101 Million Series A Financing to Usher in a New Era of Immunology Drug Development Integrating Machine Learning | Seismic Therapeutic, Inc., a biotechnology company advancing machine learning for immunology drug development, today announced its launch and financing of $101 million. The Series A was led by Lightspeed Venture Partners with participation ... |
| 09.02.2022 | Seismic Therapeutic Launches with $101M Series A | WATERTOWN, MA, Seismic Therapeutic, a biotechnology company advancing machine learning for immunology drug development, announced its launch and financing of $101 million. >> Click here for more funding data on Seismic Therapeutic ... |
| 09.02.2022 | Seismic Therapeutic Launches with $101M in Series A Financing | Seismic Therapeutic, Inc., a Watertown, Mass.-based biotechnology company advancing machine learning for immunology drug development, launched with of $101m in Series A funding. The round was led by Lightspeed Venture Partners with particip... |
| - | Seismic Therapeutic | “The Machine Learning Immunology Company | Seismic Therapeutic” |